Status: Not yet recruiting
STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump
This multi-center, prospective, randomized, double-blinded, placebo-controlled study aims to investigate whether withdrawal of aspirin from the antithrombotic regimen in patients supported with the CH-VAD pump is non-inferior to the standard antithrombotic regimen of vitamin K antagonist combined with aspirin in terms of safety and efficacy.
Participants needed: 370
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: China National Center for Cardiovascular DiseasesUpdated: Jun 12, 2026
Eligibility criteria
Age ≥18 years old; [+2]
Requirement for additional temporary or permanent mechanical circulatory support... [+6]